AllergoOncology: An immunologically relevant rodent model demonstrates safety of a tumour-specific IgE therapy (2018)

First Author: Josephs D. H.

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 73

Parent Publication: ALLERGY

ISSN: 0105-4538